COMP <GO>
HAE vs MMSI // RSI-14 & 200D SMA MOMENTUM
Haemonetics Corporation (NYSE) VS. Merit Medical Systems Inc. (NASDAQ) • 15-METRIC TALLY: HAE 6
— MMSI 6
▲ RSI-14 & 200D SMA MOMENTUM LEADER: HAE
LAST: $120.14 (+0.41%) • MKT CAP: $5.44B
rsi-technicals
63.0
LAST: $84.31 (-2.24%) • MKT CAP: $5.17B
rsi-technicals
43.5
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HAE VS. MMSI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HAE | MMSI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 59.00% | 48.70% | +10.30 | HAE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.40% | 7.80% | +0.60 | HAE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 32.5x | 23.1x | +9.40 | MMSI | /valuation <GO> |
| Free Cash Flow Yield | 4.78% | 3.87% | +0.91 | HAE | /fcf-yield <GO> |
| Operating Margin | 11.70% | 12.20% | -0.50 | MMSI | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 8.50% | -8.50 | MMSI | /net-margins <GO> |
| Revenue Growth (YoY) | -2.00% | 11.80% | -13.80 | MMSI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.89 | 4.62 | -0.73 | MMSI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | MMSI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 63.0 | 43.5 | +19.50 | HAE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 0.94 | +0.06 | HAE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 40.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.44B | $5.17B | $276.6M | HAE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HAE REV | MMSI REV | HAE GROSS % | MMSI GROSS % | HAE FCF | MMSI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.33B | $1.52B | 59.0% | 48.7% | $260.4M | $215.7M |
| FY 2024 | $1.36B | $1.36B | 55.0% | 47.4% | $142.4M | $185.7M |
| FY 2023 | $1.31B | $1.26B | — | — | $122.8M | $88.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HAE // BETA 1.00
MMSI // BETA 0.94